While the tumor tissue used to assess survival was obtained from sites of primary disease as opposed to to metastatic sites, these data indicate that CXCR4 is of potential clinical relevance and should be further investigated in the context of metastatic osteosarcoma. The gene discussed is CXCR4; the disease is neoplasm.